Skip to main content
. 2022 Feb 1;30(5):4417–4428. doi: 10.1007/s00520-022-06863-4

Table 2.

Characteristics of people with lung cancer responding to the cancer patient experience survey waves 1–5 (N = 15,967)

n %
Patient demographic
  Sex
    Male 8561 53.6
    Female 7406 46.4
  Age (years)
     < 65 5442 34.1
    65–80 9394 58.8
     > 80 1131 7.1
  Ethnicity
    White 15,405 96.5
    Non-white 562 3.5
  Index multiple deprivation
    1—least deprived 2557 16.0
    2 3222 20.2
    3 3297 20.7
    4 3354 21.0
    5—most deprived 3537 22.2
  Comorbidity score*
    0 6589 41.3
    1 3473 21.8
    2–3 2428 15.2
    4 +  3477 21.8
Cancer features
  Year of diagnosis
    2009/2010 3280 20.5
    2011 3212 20.1
    2012 3302 20.7
    2013 3028 19.0
    2014/2015 3145 19.7
  Stage
    Stage IA–IB 2884 18.1
    Stage IIA–IIB 1930 12.1
    Stage IIIA–IIIB 4547 28.5
    Stage IV 4843 30.3
    Unknown 1763 11.0
  Route of diagnosis
    Emergency presentation 2012 12.6
    GP referral 4062 25.4
    Inpatient elective 287 1.8
    Other outpatient 2161 13.5
    TWW 7318 45.8
    Missing 127 0.8
  Lung cancer type
    Carcinoid 273 1.7
    NSCLC 13,268 83.1
    SCLC 2426 15.2
Anti-cancer treatment
  Number of treatments
    0 537 3.4
    1 7216 45.2
    2 7727 48.4
    3 487 3.0
  Treatment modality
    NSCLC only
    No treatment 496 3.7
    Surgery 4945 37.3
    Chemo and radio 3750 28.3
    Chemotherapy only 2769 20.9
    Radiotherapy only 1308 9.9
    SCLC only
    No treatment 21 0.9
    Surgery 102 4.2
    Chemo and radio 1921 79.2
    Chemotherapy only 302 12.5
    Radiotherapy only 80 3.3

NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer. Deprivation quintiles presented. *Charlson index of comorbidity presented. TWW, two-week wait; GP, general practitioner (primary care)